BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

727 related articles for article (PubMed ID: 21767407)

  • 1. Longitudinal numbers-needed-to-treat (NNT) for achieving various levels of analgesic response and improvement with etoricoxib, naproxen, and placebo in ankylosing spondylitis.
    Peloso PM; Gammaitoni A; Smugar SS; Wang H; Moore AR
    BMC Musculoskelet Disord; 2011 Jul; 12():165. PubMed ID: 21767407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study.
    van der Heijde D; Baraf HS; Ramos-Remus C; Calin A; Weaver AL; Schiff M; James M; Markind JE; Reicin AS; Melian A; Dougados M
    Arthritis Rheum; 2005 Apr; 52(4):1205-15. PubMed ID: 15818702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, clinical trial to assess the relative efficacy and tolerability of two doses of etoricoxib versus naproxen in patients with ankylosing spondylitis.
    Balazcs E; Sieper J; Bickham K; Mehta A; Frontera N; Stryszak P; Popmihajlov Z; Peloso PM
    BMC Musculoskelet Disord; 2016 Oct; 17(1):426. PubMed ID: 27737664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice.
    Moore RA; Moore OA; Derry S; Peloso PM; Gammaitoni AR; Wang H
    Ann Rheum Dis; 2010 Feb; 69(2):374-9. PubMed ID: 19364730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of cyclo-oxygenase-2 inhibition by etoricoxib and naproxen on the axial manifestations of ankylosing spondylitis in the presence of peripheral arthritis.
    Gossec L; van der Heijde D; Melian A; Krupa DA; James MK; Cavanaugh PF; Reicin AS; Dougados M
    Ann Rheum Dis; 2005 Nov; 64(11):1563-7. PubMed ID: 15731291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analgesic efficacy of etoricoxib in primary dysmenorrhea: results of a randomized, controlled trial.
    Malmstrom K; Kotey P; Cichanowitz N; Daniels S; Desjardins PJ
    Gynecol Obstet Invest; 2003; 56(2):65-9. PubMed ID: 12900528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, parallel-group study comparing the analgesic effect of etoricoxib to placebo, naproxen sodium, and acetaminophen with codeine using the dental impaction pain model.
    Malmstrom K; Kotey P; Coughlin H; Desjardins PJ
    Clin J Pain; 2004; 20(3):147-55. PubMed ID: 15100590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multinational randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis [ISRCTN25142273].
    Collantes E; Curtis SP; Lee KW; Casas N; McCarthy T; Melian A; Zhao PL; Rodgers DB; McCormick CL; Lee M; Lines CR; Gertz BJ;
    BMC Fam Pract; 2002 May; 3():10. PubMed ID: 12033987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Numbers needed to treat calculated from responder rates give a better indication of efficacy in osteoarthritis trials than mean pain scores.
    Moore RA; Moore OA; Derry S; McQuay HJ
    Arthritis Res Ther; 2008; 10(2):R39. PubMed ID: 18384679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etoricoxib provides analgesic efficacy to patients after knee or hip replacement surgery: a randomized, double-blind, placebo-controlled study.
    Rasmussen GL; Malmstrom K; Bourne MH; Jove M; Rhondeau SM; Kotey P; Ang J; Aversano M; Reicin AS;
    Anesth Analg; 2005 Oct; 101(4):1104-1111. PubMed ID: 16192529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost effectiveness of etoricoxib versus celecoxib and non-selective NSAIDS in the treatment of ankylosing spondylitis.
    Jansen JP; Gaugris S; Choy EH; Ostor A; Nash JT; Stam W
    Pharmacoeconomics; 2010; 28(4):323-44. PubMed ID: 20222755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis.
    Matsumoto AK; Melian A; Mandel DR; McIlwain HH; Borenstein D; Zhao PL; Lines CR; Gertz BJ; Curtis S;
    J Rheumatol; 2002 Aug; 29(8):1623-30. PubMed ID: 12180720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etoricoxib--preemptive and postoperative analgesia (EPPA) in patients with laparotomy or thoracotomy--design and protocols.
    Fleckenstein J; Kramer S; Offenbächer M; Schober G; Plischke H; Siebeck M; Mussack T; Hatz R; Lehmeyer L; Lang PM; Heindl B; Conzen P; Irnich D
    Trials; 2010 May; 11():66. PubMed ID: 20504378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single dose oral etoricoxib for acute postoperative pain in adults.
    Clarke R; Derry S; Moore RA
    Cochrane Database Syst Rev; 2012 Apr; (4):CD004309. PubMed ID: 22513922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etoricoxib in acute pain associated with dental surgery: a randomized, double-blind, placebo- and active comparator-controlled dose-ranging study.
    Malmstrom K; Sapre A; Couglin H; Agrawal NG; Mazenko RS; Fricke JR
    Clin Ther; 2004 May; 26(5):667-79. PubMed ID: 15220011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pain management after elective hallux valgus surgery: a prospective randomized double-blind study comparing etoricoxib and tramadol.
    Brattwall M; Turan I; Jakobsson J
    Anesth Analg; 2010 Aug; 111(2):544-9. PubMed ID: 20584877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing etoricoxib and celecoxib for preemptive analgesia for acute postoperative pain in patients undergoing arthroscopic anterior cruciate ligament reconstruction: a randomized controlled trial.
    Boonriong T; Tangtrakulwanich B; Glabglay P; Nimmaanrat S
    BMC Musculoskelet Disord; 2010 Oct; 11():246. PubMed ID: 20973952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of chronic low back pain with etoricoxib, a new cyclo-oxygenase-2 selective inhibitor: improvement in pain and disability--a randomized, placebo-controlled, 3-month trial.
    Birbara CA; Puopolo AD; Munoz DR; Sheldon EA; Mangione A; Bohidar NR; Geba GP;
    J Pain; 2003 Aug; 4(6):307-15. PubMed ID: 14622687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analgesic efficacy of the cyclooxygenase-inhibiting nitric oxide donor AZD3582 in postoperative dental pain: Comparison with naproxen and rofecoxib in two randomized, double-blind, placebo-controlled studies.
    Michael Hill C; Sindet-Pederson S; Seymour RA; Hawkesford JE; Coulthard P; Lamey PJ; Gerry Cowan C; Wickens M; Jeppsson L; Dean AD; Svensson O
    Clin Ther; 2006 Sep; 28(9):1279-95. PubMed ID: 17062301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative use of etoricoxib reduces pain and opioid side-effects after total abdominal hysterectomy: a double-blind, randomized, placebo-controlled phase III study.
    Viscusi ER; Frenkl TL; Hartrick CT; Rawal N; Kehlet H; Papanicolaou D; Gammaitoni A; Ko AT; Morgan LM; Mehta A; Curtis SP; Peloso PM
    Curr Med Res Opin; 2012 Aug; 28(8):1323-35. PubMed ID: 22738802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.